Heart Palpitations in Breast Cancer: What’s Typical, Why They Happen, and How to Manage Them

Heart palpitations (a fast, pounding, or irregular heartbeat) are not a classic symptom of breast cancer itself, but they can occur for several reasons around diagnosis and treatment. They are more commonly linked to anxiety, menopausal hot flashes from hormone therapy, or cardiotoxic effects of certain cancer treatments rather than the tumor itself. [PM7] [PM8] Some chemotherapy and targeted therapies can affect heart function and may trigger palpitations, shortness of breath, or chest discomfort, which warrants prompt medical attention. ^{[1] [2]}

---

How Common Is It?

• Before surgery, a notable subset of people with breast cancer report palpitations, often alongside anxiety, sleep disturbance, fatigue, and pain. This suggests palpitations may co‑travel with stress and symptom burden more than with the cancer itself. [PM7]
• During or after treatment, palpitations can appear as part of hot flashes (heat, flushing, sweating, chills, palpitations, night sweats, anxiety), particularly with estrogen‑blocking therapies. [PM8]
• Palpitations can also signal treatment‑related cardiac effects depending on the drug class and individual risk factors. ^{[3] [4]}

---

Main Causes

1) Non‑cancer causes (very common)

• Stress and anxiety around diagnosis and treatment frequently provoke palpitations. ^{[5] [6]}
• Stimulants and medications (caffeine, nicotine, some decongestants like pseudoephedrine) can trigger palpitations. ^{[5] [7]}
• Hormonal changes with menopause or menopause‑like states from therapy can bring palpitations via hot flashes. ^[8] [PM8]
• Thyroid overactivity (hyperthyroidism) or anemia (low blood count) can cause the heart to beat faster or harder. ^{[9] [10]}

2) Cancer therapy effects (cardiotoxicity)

• Anthracyclines (e.g., doxorubicin) can cause dose‑related cardiomyopathy and heart rhythm changes; risk rises with cumulative dose and certain patient factors. ^{[3] [11]}
• HER2‑directed therapies (trastuzumab, pertuzumab) can reduce heart pumping strength and, less commonly, lead to symptomatic heart failure, sometimes necessitating therapy interruption. ^{[12] [13]}
• Combination of trastuzumab with chemotherapy increases late‑onset heart failure risk compared to chemo alone, especially within the first two years. ^[4]
• Fluoropyrimidines (e.g., capecitabine) can cause chest pain, tachycardia, arrhythmias, or even heart attack, particularly in those with prior coronary disease. ^[14] [PM25]

3) Hot flashes from therapy

• Hormone‑blocking treatments often cause hot flashes that may include palpitations and anxiety, disrupting sleep and quality of life. [PM8]

---

Red Flags That Need Prompt Care

• Fast or irregular heartbeats, chest pain or heaviness, and new shortness of breath especially with activity should be reported promptly to your care team. These signs can indicate treatment‑related heart effects. ^{[1] [2]}
• During breast cancer therapy, clinicians may recommend heart tests before and during treatment to monitor for cardiotoxicity. ^{[1] [2]}

---

How Palpitations Are Evaluated

• History and exam: triggers (caffeine, medications), timing with treatments, associated symptoms (chest pain, breathlessness, fainting). ^{[5] [6]}
• Tests: ECG to check rhythm; blood tests for anemia and thyroid; echocardiogram (heart ultrasound) if therapy‑related cardiotoxicity is suspected or if symptoms are significant. ^{[3] [4]}
• Medication review: identify drugs that can worsen palpitations or interact with anticoagulants, if relevant. ^[15] [PM11]

---

Management Options

Address triggers and underlying causes

• Reduce stimulants (caffeine, nicotine, certain decongestants) and manage stress; this often lessens palpitations. ^{[5] [7]}
• Treat medical contributors like hyperthyroidism or anemia to reduce strain on the heart. ^{[9] [10]}

Manage hot flashes that include palpitations

• Non‑drug strategies: cooling techniques, layered clothing, avoiding alcohol/spicy foods, paced breathing, and sleep hygiene may ease hot flashes and palpitations. [PM8]
• Medication options can be considered if lifestyle changes aren’t enough; choices depend on cancer treatment context and safety. [PM8]

Cardio‑oncology care for treatment‑related effects

• If palpitations occur with chest pain, breathlessness, or abnormal testing, cancer therapy may need to be paused and cardiology consultation arranged. ^{[14] [13]}
• For reduced heart function, guideline‑directed medications (ACE inhibitors and beta‑blockers) are commonly used to improve symptoms and support heart recovery. ^[16]
• Future treatment choices may be tailored to lower heart risk (e.g., using non‑anthracycline regimens when appropriate). ^[11]
• Ongoing heart monitoring during HER2‑directed or anthracycline therapy is typical to catch changes early. ^{[12] [4]}

---

Practical Tips You Can Try

• Track episodes: note time, duration, triggers (caffeine, stress, medications), and associated symptoms to share with your team. ^{[5] [6]}
• Check labels: avoid cold remedies containing pseudoephedrine or phenylephrine unless approved by your clinician. ^[5]
• Support heart health: manage blood pressure and cholesterol, stay active as tolerated, and avoid smoking to reduce overall cardiovascular risk during cancer care. ^[17]

---

When to Seek Immediate Help

• Sudden chest pain, severe shortness of breath, fainting, or a racing heartbeat that doesn’t settle especially during chemotherapy or HER2 therapy needs urgent evaluation. ^{[1] [2]}
• Any new or worsening palpitations while on capecitabine should be discussed promptly; rechallenge after cardiotoxicity is often discouraged. ^[14] [PM25]

---

Bottom Line

• Palpitations are not a hallmark symptom of breast cancer itself; they more often reflect stress, hot flashes, or treatment effects. [PM7] [PM8]
• Because some breast cancer therapies can affect the heart, any persistent or concerning palpitations should be shared with your care team for appropriate testing and management. ^{[1] [4]}

---